Lindis Biotech GmbH | WebDisclosure

BRIEF

published on 11/19/2024 at 10:12, 1 month 2 days ago

LINDIS Biotech Partners with Pharmanovia for Catumaxomab Launch

Cancer Therapy Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
BRIEF

published on 11/19/2024 at 10:12, 1 month 2 days ago

LINDIS Biotech s'associe à Pharmanovia pour le lancement du Catumaxomab

Thérapie Contre Le Cancer Catumaxomab Ascite Maligne LINDIS Biotech Pharmanovia
PRESS RELEASE

published on 11/19/2024 at 10:07, 1 month 2 days ago

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
LINDIS Biotech signs licensing agreement with Pharmanovia for the commercialization of Catumaxomab, a trifunctional bi-specific monoclonal antibody for malignant ascites treatment

Licensing Agreement Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
BRIEF

published on 10/21/2024 at 09:05, 2 months ago

LINDIS Biotech Achieves Key Milestone for Cancer Treatment in Europe

European Commission CHMP Approval KORJUNY® Malignant Ascites Catumaxomab
BRIEF

published on 10/21/2024 at 09:05, 2 months ago

LINDIS Biotech franchit une étape clé dans le traitement du cancer en Europe

Commission Européenne KORJUNY® Catumaxomab Approbation Du CHMP Ascite Maligne
PRESS RELEASE

published on 10/21/2024 at 09:00, 2 months ago

LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union
LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union, becoming the only drug approved for intraperitoneal treatment of malignant ascites in adults with EpCAM-positive carcinomas

CHMP Opinion Malignant Ascites Catumaxomab LINDIS Biotech KORJUNY

Published on 12/21/2024 at 01:30, 17 hours 33 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 33 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 58 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 3 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 33 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 12 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 18 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 53 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 45 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 45 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News